LivaNova (Nasdaq: LIVN) today announced its new strategic roadmap and long-range financial plan at its 2025 Investor Day.

The benchmark Russell 2000® Growth Index was up 12.19% for the quarter. Trailing the benchmark, the Wasatch Ultra Growth Fund ...

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

These new noise-canceling earbuds from value brand Baseus include Sound by Bose. They deliver surprisingly good performance ...

Esperion Therapeutics, Inc. and C4 Therapeutics, Inc. were among the top contributors to performance. SiTime Corp. was also a top contributor. The company provides silicon timing chips for a wide ...